Biotech for Homeland Security to be Addressed at BIOPHEX Conference and Exhibition, San Jose, CA, September 23-25, 2003.Business Editors BIOWIRE2K LARCHMONT, N.Y.--(BUSINESS WIRE)--Sept. 16, 2003 The "Role of Biotechnology in Homeland Security" will be the topic of the keynote address during the BIOPHEX Conference and Exhibition from September 23-25, at the San Jose McEnery Convention Center in San Jose, California San Jose (IPA: /ˌsænhoʊˈzeɪ/) is the third-largest city in California, and the tenth-largest in the United States. It is the county seat of Santa Clara County. . J. Patrick Fitch, Ph.D., Program Leader for Chemical and Biological Countermeasures and National Security (CBNP CBNP Chemical and Biological National Security Program (US government) CBNP CAFP (Caribbean Agriculture & Fisheries Programme) Biotechnology Network Project CBNP Community-Based Nutrition Programme ), University of California The University of California has a combined student body of more than 191,000 students, over 1,340,000 living alumni, and a combined systemwide and campus endowment of just over $7.3 billion (8th largest in the United States). , Lawrence Livermore National Laboratory Lawrence Livermore National Laboratory: see Lawrence Berkeley National Laboratory. (body) Lawrence Livermore National Laboratory - (LLNL) A research organaisatin operated by the University of California under a contract with the US Department of Energy. , will deliver the keynote. Leading researchers, chief scientific officers, lab and IT directors, pharmaceutical engineers, process development managers, quality control specialists, and others engaged in the biopharmaceutical industry will convene at the three-day conference and scientific program, put together by the editors of Genetic Engineering News. The meeting includes a three-track program focusing on monoclonal antibodies, vaccines, and proteomics. Among the key speakers at BIOPHEX are Dr. Una Ryan, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , AVANT Immunotherapeutics; and Dr. Bruce Seligmann, CEO, High Throughput Genomics. In addition, Wednesday's track on proteomics will include a session on the applications of proteomics to bioprocess bi·o·proc·ess n. 1. A technique that produces a biological material, such as a genetically engineered microbial strain, for commercial use. 2. operations. A two-day exhibition with over 200 technology vendors complements the BIOPHEX conference, along with a job fair and poster sessions. BIOPHEX is sponsored by Genetic Engineering News (www.genengnews.com) and organized by REED Exhibitions. For a complete program and registration information, visit www.biophex.com. |
|
||||||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion